Tra2-alpha: A Protein with Potential as A Drug Target and Biomarker

Target Name: TRA2A

NCBI ID: G29896

Tra2-alpha: A Protein with Potential as A Drug Target and Biomarker

Tra2-alpha is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and intestines. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of Tra2-alpha is its role in the regulation of immune cell function. It is a transcription factor that regulates the expression of genes involved in immune response, and it has been shown to play a key role in the development and maintenance of immune tolerance.

In addition to its role in immune regulation, Tra2-alpha is also involved in a number of other processes in the body. For example, it is involved in the regulation of cell death, and has been shown to play a key role in the regulation of cell apoptosis. It is also involved in the regulation of cell signaling, and has been shown to play a key role in the regulation of cell proliferation.

Tra2-alpha has also been shown to be involved in a number of diseases, including cancer. For example, it has been shown to be involved in the regulation of the development and progression of cancer, and has been shown to play a key role in the regulation of cancer cell metastasis.

In addition to its involvement in disease, Tra2-alpha is also an attractive drug target. Because it has been shown to play a key role in a number of diseases, and its regulation by various signaling pathways makes it a potential target for small molecules.

Tra2-alpha has also been shown to have a number of potential therapeutic applications. For example, it has been shown to be involved in the regulation of the immune response, and has been shown to play a key role in the development and maintenance of immune tolerance. This makes it a potential target for therapies that aim to enhance or restore the immune response.

Tra2-alpha has also been shown to be involved in the regulation of cell death, and has been shown to play a key role in the regulation of cell apoptosis. This makes it a potential target for therapies that aim to enhance or restore cell death regulation.

In addition to its potential therapeutic applications, Tra2-alpha is also a potential biomarker. Because it is involved in a number of processes in the body, it has been shown to be a potential indicator of disease, and its levels have been proposed as a potential diagnostic biomarker.

Overall, Tra2-alpha is a protein that has the potential to be a drug target or biomarker. Its role in immune regulation and its involvement in a number of diseases make it a promising target for small molecules, and its potential as a biomarker make it an attractive option for diagnostic applications. Further research is needed to fully understand its role and potential as a drug target and biomarker.

Protein Name: Transformer 2 Alpha Homolog

Functions: Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing

More Common Targets